Obexelimab (XmAb5871) is a bifunctional monoclonal antibody that binds to both CD19 and FcgammaRIIb, inhibiting the activity of B cells, plasma cells, and plasma cell precursors. Obexelimab is used in the study of autoimmune diseases such as systemic lupus erythematosus.
Purity:
98.00%
CAS Number:
[1690307-05-1]
Target:
Immunology/Inflammation related|||Apoptosis
T81624
* VAT and and shipping costs not included. Errors and price changes excepted